Critical Regulatory Paths to Value Inflection

Thursday 25 February 2021, 14:00-15:00

Registration is now closed. Please contact to be added to the waitlist.

The webinar will discuss the ATMP sector, why it is exciting from a technical point of view and what opportunities there are to utilise new and innovative regulatory pathways to get these medicinal products to market, whilst ensuring that the desire for innovation is balanced with the requirement for a robust commercial strategy.

Our webinar will also explore how such critical path thinking impacts investment decisions and is factored into deal structure.

14:00 Welcome from One Nucleus
Alicia Gailliez, One Nucleus
14:05 Regulatory routes for value inflection points
Kate Coleman, Director/Principal Consultant, PharmaLex
14:30 Discussion: How does the regulatory regime for cell and gene therapies impact investment decisions?
Julian Hitchcock, Of Counsel, Bristows LLP
Dominic Schmidt, Partner, Syncona
14:50 Q&A
15:00 Close



Registration is free and open to all.


February 25th, 2021 from  2:00 PM to  3:00 PM
Belgium Embassy, 17, Grosvenor Crescent
London, SW1X 7EE
United Kingdom
Phone: 01223 896450
Phone: 01223 896456